Regeneron

Amgen: Looking for a Wild Card
Barron's
Tue, 03/17/15 - 08:11 am
Amgen
PCSK9 inhibitors
Regeneron
AMG-145
New Cholesterol Drugs: Highly Effective But Important Questions Remain
Forbes
Mon, 03/16/15 - 09:08 am
PCSK9 inhibitors
alirocumab
evolocumab
Amgen
Sanofi
Regeneron
Is The Biotechnology Bubble Turning Into Mania?
Forbes
Mon, 03/16/15 - 09:03 am
biotech
Gilead Sciences
Amgen
Regeneron
Puma Biotechnology
Isis Pharmaceuticals
Pharmacyclics
Intercept Pharmaceuticals
The 4 Biggest Biotech Stocks In The Market
Yahoo/Benzinga
Thu, 03/12/15 - 07:55 am
biotech
Celgene
Regeneron
Biogen Idec
Amgen
Gilead Sciences
Biotech pros' top 8 stock picks
Fortune
Mon, 03/9/15 - 11:59 am
biotech
Bluebird Bio
Chimerix
Puma Biotechnology
Incyte
Isis Pharmaceuticals
Celgene
Alexion
Regeneron
The Top 10 Biotech Companies In The U.S.
Forbes
Fri, 03/6/15 - 11:43 am
biotech
Gilead Sciences
Amgen
Celgene
Biogen Idec
Regeneron
Alexion
Vertex Pharmaceuticals
Illumina
Biomarin
Agilent
Exclusive: Regeneron, Sanofi outline promising PhIIb data for top blockbuster pick dupilumab
Fierce Biotech
Mon, 02/23/15 - 08:47 am
Sanofi
Regeneron
dupilumab
PCSK9 inhibitors
Regeneron Beats Genentech In Rare Face Off Over Diabetes-Related Vision Loss
Forbes
Thu, 02/19/15 - 10:38 am
Regeneron
Genentech
diabetes
Eylea
Lucentis
DME
diabetic macular edema
3 Upcoming FDA Decisions We're Most Excited About
Motley Fool
Mon, 02/16/15 - 12:00 pm
FDA
Celgene
Revlimid
Multiple Myeloma
Regeneron
Eylea
Vertex Pharmaceuticals
Kalydeco
lumacaftor
Why Regeneron's Risk-Reward Looks Good Again
Seeking Alpha
Fri, 02/13/15 - 09:08 am
Regeneron
Regeneron says its allergy drug could be as big as PCSK9 blockers
Fierce Pharma
Wed, 02/11/15 - 05:40 pm
Regeneron
allergies
Sanofi
dupilumab
Regeneron revenue beats Street on strong Eylea sales
Yahoo/Reuters
Tue, 02/10/15 - 08:45 am
Regeneron
earnings
How Regeneron Pharmaceuticals, Sanofi, And Amgen Will Weather The Inevitable Price Wars
Seeking Alpha
Wed, 02/4/15 - 01:18 pm
Regeneron
Sanofi
Amgen
drug pricing
This Tiny Biotech Hopes to Capture a Share of This $6 Billion Market
Motley Fool
Mon, 02/2/15 - 10:08 am
Ophthotech
Novartis
Regeneron
Fovista
Roche
Avastin
Eylea
Lucentis
wet age-related macular degeneration
Drugmakers receive mysterious invites to White House
CNBC
Wed, 01/28/15 - 08:00 pm
R&D
personalized medicine
Obama
Merck
Regeneron
Vertex Pharmaceuticals
Sanofi and Regeneron Gain Edge on Amgen in Cholesterol Drug Race
Bloomberg
Mon, 01/26/15 - 08:08 am
Sanofi
Regeneron
Amgen
alirocumab
evolocumab
PCSK9 inhibitors
Benefits firms shouldn't play drug favorites: CEO
CNBC
Tue, 01/20/15 - 09:12 am
PBMs
Regeneron
Leonard Schleifer
Express Scripts
FirstWord Lists – The drugs that will shape 2015
First Word Pharma
Mon, 01/19/15 - 04:14 pm
Harvoni
Viekira Pak
Gilead Sciences
AbbVie
alirocumab
evolocumab
Amgen
Regeneron
Sanofi
Opdivo
Keytruda
Merck
Bristol-Myers Squibb
Novartis
CTL019
Zarxio
Pfizer
palbociclib
Saxenda
Trulicity
Afrezza
MannKind
Eli Lilly
Novo Nordisk
LCZ696
Toujeo
Breo Ellipta
GED-0301
Celgene
BiogenIdec
After Roiling Hepatitis Market, Express Scripts Turns to Cholesterol
Bloomberg
Wed, 01/14/15 - 10:08 am
hepatitis C
Express Scripts
Regeneron
Amgen
PCSK9 inhibitor
Express Scripts CEO: Amgen, Regeneron Among Targets for Drug Discounting
TheStreet.com
Tue, 01/13/15 - 04:46 pm
Express Scripts
drug pricing
Amgen
Regeneron

Pages